Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Passenger's disruptive behavior on American Airlines flight leads to dramatic intervention by crew and passengers, underscoring the importance of cooperation in maintaining flight safety.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Passenger's disruptive behavior on American Airlines flight leads to dramatic intervention by crew and passengers, underscoring the importance of cooperation in maintaining flight safety.